To clarify this, we raised a function-blocking polyclonal antibody (pAb) that has been shown to block the interaction of ENO1 with plasminogen and its pro-migratory ability for cancer cells (32, 53), enabling us to specifically determine the functional importance of sENO1 in the invadopodia and the invasiveness of CSCs. Here, ENO1 is linked to cancer.